NCT00081874 2025-04-27RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell LymphomaM.D. Anderson Cancer CenterPhase 1/2 Completed29 enrolled
NCT01075321 2020-10-22Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaMayo ClinicPhase 1/2 Completed58 enrolled 12 charts
NCT00918333 2020-03-10Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin LymphomaMayo ClinicPhase 1/2 Completed124 enrolled 10 charts
NCT00474929 2019-08-20Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaMayo ClinicPhase 1/2 Completed103 enrolled 12 charts